Massar Capital Management, LP

Position in TGTX — Tg Therapeutics, Inc.

CIK 2037238 STAMFORD, CT

Position in TGTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$333,163

New position

Shares Held

10,029

first reported quarter

Ownership

0.007%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Massar Capital Management, LP holds $7,816,276 across 4 Biotechnology names. TGTX ranks #3 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	QURE	uniQure N.V.	426,029	$6,965,574
2	CPRX	Catalyst Pharmaceuticals, Inc.	15,382	$380,858
3	TGTX	Tg Therapeutics, Inc. This page	10,029	$333,163
4	ADMA	Adma Biologics, Inc.	15,170	$136,681

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$333,163	10,029	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.